12/1
07:03 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
12/1
07:03 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
12/1
06:30 am
nmra
Rating for NMRA
Report
Rating for NMRA
12/1
06:30 am
nmra
Rating for NMRA
Report
Rating for NMRA
12/1
05:35 am
nmra
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
12/1
05:35 am
nmra
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
11/17
08:48 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
10/28
07:39 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
10/28
07:39 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
10/27
08:34 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock.
10/27
08:34 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Medium
Report
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $14.00 price target on the stock.
10/27
08:17 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
10/27
08:17 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
10/27
08:00 am
nmra
Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim
Medium
Report
Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim
10/27
08:00 am
nmra
Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim
Medium
Report
Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim
9/16
08:07 am
nmra
Neumora Therapeutics (NASDAQ:NMRA) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Report
Neumora Therapeutics (NASDAQ:NMRA) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
9/16
06:38 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
9/16
05:09 am
nmra
Neumora Therapeutics downgraded to Underweight from Neutral at JPMorgan
Medium
Report
Neumora Therapeutics downgraded to Underweight from Neutral at JPMorgan